Nuveen Churchill: JV Accretion and the Nonaccrual Watch
Private credit BDC leans on a new levered joint venture while credit blemishes creep into the core middle market book.
NCDL · Earnings Call · 2026-08-06
Strategic Pivot: The Joint Venture
NCDL's second-half 2026 script is written around a joint venture. In July, the BDC seeded a $106 million equity commitment with an institutional partner, selling down ~$150 million of first-lien loans at launch with a target to ramp to ~$300 million. Management frames this as both accretive and capacity-creating: "a manageable level of leverage at the JV, and we believe this equity investment will be accretive to NCDL's long-term earnings profile" (“a manageable level of leverage at the JV, and we believe this equity investment will be accretive to NCDL's long-term earnings profile” — Kenneth Kencel, Chairman, President and CEO · 2026-08-06, Ken Kencel). CFO Shai Vichness added the JV will employ roughly 2x leverage, generating "incremental returns... accretive to the overall earnings profile" (“that will allow us to generate those incremental returns and be accretive to the overall earnings profile of NCDL” — Shaul Vichness, Chief Financial Officer and Treasurer · 2026-08-06). The JV is a deliberate use of the BDC's balance sheet at a time when gross originations collapsed to $12M in Q2 from $83M in Q1, partly due to deliberate leverage management. The trade is the levered senior first-lien loan, which appears as senior trade in the latest quarter. Management's commitment to this structure is consistent with prior—last quarter they cited the capital appreciation angle, and now the JV gives it a concrete vehicle.Credit: Blemishes Appear but Stay Idiosyncratic
The quarter's credit noise is the counterweight. NCDL added 4 nonaccruals, pushing nonaccruals to 2.7% of cost (1.5% of fair value), and the watch list ticked to 10.8% from 8.4%. Management stresses there is "no common theme... very much idiosyncratic" (“very much idiosyncratic. There really is no theme. And in each case, in each of the 4, we did have ongoing sponsor support” — Kenneth Kencel, Chairman, President and CEO · 2026-08-06, Ken Kencel). They also point to diversified industries and stable portfolio leverage (5.2x net, 2.5x interest coverage). The overall BDC continues to emphasize a defensive book, and the credit story is unchanged: core middle market remains the ballast. However, the fundamentals paint a mixed picture. Net income has been on a rough path: after peaking at $29M in Q4 2024, it fell to $9M by Q2 2026. The trend line shows the volatility—Net income has fallen sequentially from $19M to $9M, a -49% drawdown from the 2024 peak. This is the backdrop for the JV: lean on the senior trade to stabilize earnings.Capital Structure: Optimizing Debt, Keeping the Dividend
Two post-quarter transactions shape the funding profile: redemption of CLO III (SOFR+211) and a $100M tap of the 2030 unsecured notes—taken entirely by parent TIAA. The pro forma weighted average cost of debt stays ~SOFR+188, and unsecured notes now represent ~41% of outstanding debt. The unsecured note move adds operational flexibility while preserving investment-grade ratings. This was a recurring theme from prior quarters—management has consistently worked to lower borrowing costs (seen in the borrowing costs keyword). Dividend coverage remains intact: Q2 NII of $0.41 covers the $0.36 base distribution, and management declared a $0.38 total for Q3 (regular + $0.02 supplemental). They continue to pay out a portion of excess earnings, a policy that dates back to 2025 calls. As one analyst noted last year, "you should think about cutting the dividend or reevaluating" (“maybe you should think about cutting the dividend or reevaluating that” — Brian Mckenna, Analyst · 2025-11-04). NCDL has held the line, but the earnings cushion is thinner now. The real tension in this report is that the BDC's growth engine—the JV—depends on deal flow that has been volatile. Gross originations fell 85% QoQ, and even platform-level activity ($4.3B) lagged 2025's pace. Management insists the pipeline is recovering ("in June and July, we experienced a material increase in deals reviewed" (“in June and July, we experienced a material increase in deals reviewed” — Kenneth Kencel, Chairman, President and CEO · 2026-08-06)), but the second-quarter numbers are undeniably weak. The market has already priced some skepticism: the stock is down 31% since its 2024 high and trades around a 17% discount to NAV.Forward View: Watch the Watch List
The next quarter hinges on two things: whether the JV ramps as promised (targeting $300M in assets within 12 months) and whether the overall industry credit concerns translate into more NCDL nonaccruals. Management's confidence is high, but the trend is not entirely supportive. Our read: the JV is a positive structural move, but the elevated watch list and the steep drop in originations argue for a wait-and-see. As Ken said, "we feel very positive as to how we are positioned relative to the risk that AI may pose" (“we feel very positive as to how we are positioned relative to the risk that AI may pose to our portfolio companies” — Kenneth Kencel, Chairman, President and CEO · 2026-08-06)—but the positioning itself is now being tested.This remains the thesis. The next report will show whether the JV and credit discipline hold the line.We have constructed a defensive portfolio balanced across multiple measures, including sponsor, position size as well as industry and sector concentration.